246 related articles for article (PubMed ID: 32317964)
1. Systems Pharmacology Approach to Investigate the Mechanism of Kai-Xin-San in Alzheimer's Disease.
Luo Y; Li D; Liao Y; Cai C; Wu Q; Ke H; Liu X; Li H; Hong H; Xu Y; Wang Q; Fang J; Fang S
Front Pharmacol; 2020; 11():381. PubMed ID: 32317964
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic Mechanism of Kai Xin San on Alzheimer's Disease Based on Network Pharmacology and Experimental Validation.
Wang K; Yang R; Chen TT; Qin MR; Wang P; Kong MW
Chin J Integr Med; 2023 May; 29(5):413-423. PubMed ID: 36474082
[TBL] [Abstract][Full Text] [Related]
3. Kai-Xin-San Inhibits Tau Pathology and Neuronal Apoptosis in Aged SAMP8 Mice.
Jiao YN; Zhang JS; Qiao WJ; Tian SY; Wang YB; Wang CY; Zhang YH; Zhang Q; Li W; Min DY; Wang ZY
Mol Neurobiol; 2022 May; 59(5):3294-3309. PubMed ID: 35303280
[TBL] [Abstract][Full Text] [Related]
4. Integrated meta-analysis, network pharmacology, and molecular docking to investigate the efficacy and potential pharmacological mechanism of Kai-Xin-San on Alzheimer's disease.
Yi P; Zhang Z; Huang S; Huang J; Peng W; Yang J
Pharm Biol; 2020 Dec; 58(1):932-943. PubMed ID: 32956608
[TBL] [Abstract][Full Text] [Related]
5. Classic Famous Prescription Kai-Xin-San Ameliorates Alzheimer's Disease via the Wnt/β-Catenin Signaling Pathway.
Shan X; Lv S; Huang P; Zhang W; Jin C; Liu Y; Li Y; Jia Y; Chu X; Peng C; Zhang C
Mol Neurobiol; 2024 Apr; 61(4):2297-2312. PubMed ID: 37874481
[TBL] [Abstract][Full Text] [Related]
6. Exploring the anti-ferroptosis mechanism of Kai-Xin-San against Alzheimer's disease through integrating network pharmacology, bioinformatics, and experimental validation strategy in vivo and in vitro.
Yan C; Yang S; Shao S; Zu R; Lu H; Chen Y; Zhou Y; Ying X; Xiang S; Zhang P; Li Z; Yuan Y; Zhang Z; Wang P; Xie Z; Wang W; Ma H; Sun Y
J Ethnopharmacol; 2024 May; 326():117915. PubMed ID: 38360383
[TBL] [Abstract][Full Text] [Related]
7. Kai-Xin-San Improves Cognitive Impairment via Wnt/β-Catenin and IRE1/XBP1s Signalings in APP/PS1 Mice.
Xu YM; Lu FM; Xu HC; Zhang J; Hei SY; Qiu YH; Cai YF; Zhang SJ; Zhao M
Rejuvenation Res; 2023 Jun; 26(3):105-115. PubMed ID: 37073462
[TBL] [Abstract][Full Text] [Related]
8. Kai-xin-san improves cognitive impairment in D-gal and Aβ
Wang H; Zhou L; Zheng Q; Song Y; Huang W; Yang L; Xiong Y; Cai Z; Chen Y; Yuan J
J Ethnopharmacol; 2024 Jul; 329():118161. PubMed ID: 38599474
[TBL] [Abstract][Full Text] [Related]
9. Metabolomics approach to explore the effects of Kai-Xin-San on Alzheimer's disease using UPLC/ESI-Q-TOF mass spectrometry.
Chu H; Zhang A; Han Y; Lu S; Kong L; Han J; Liu Z; Sun H; Wang X
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Mar; 1015-1016():50-61. PubMed ID: 26896572
[TBL] [Abstract][Full Text] [Related]
10. Chinese Medicine Formula Kai-Xin-San Ameliorates Neuronal Inflammation of CUMS-Induced Depression-like Mice and Reduces the Expressions of Inflammatory Factors via Inhibiting TLR4/IKK/NF-κB Pathways on BV2 Cells.
Qu S; Liu M; Cao C; Wei C; Meng XE; Lou Q; Wang B; Li X; She Y; Wang Q; Song Z; Han Z; Zhu Y; Huang F; Duan JA
Front Pharmacol; 2021; 12():626949. PubMed ID: 33790789
[TBL] [Abstract][Full Text] [Related]
11.
Xu YM; Wang XC; Xu TT; Li HY; Hei SY; Luo NC; Wang H; Zhao W; Fang SH; Chen YB; Guan L; Fang YQ; Zhang SJ; Wang Q; Liang WX
Neural Regen Res; 2019 May; 14(5):794-804. PubMed ID: 30688265
[TBL] [Abstract][Full Text] [Related]
12. Classic Prescription, Kai-Xin-San, Ameliorates Alzheimer's Disease as an Effective Multitarget Treatment: From Neurotransmitter to Protein Signaling Pathway.
Guo S; Wang J; Xu H; Rong W; Gao C; Yuan Z; Xie F; Bi K; Zhang Z; Li Q
Oxid Med Cell Longev; 2019; 2019():9096409. PubMed ID: 31354916
[TBL] [Abstract][Full Text] [Related]
13. Kai-Xin-San protects against mitochondrial dysfunction in Alzheimer's disease through SIRT3/NLRP3 pathway.
Su S; Chen G; Gao M; Zhong G; Zhang Z; Wei D; Luo X; Wang Q
Chin Med; 2023 Mar; 18(1):26. PubMed ID: 36918872
[TBL] [Abstract][Full Text] [Related]
14. Study on the chemical constituents and mechanism of Kai-Xin-San based on UPLC-Q-Exactive MS and network pharmacology.
Shang B; Jia S; Zhang T; Gao F; Lu M; Chen K; Jiao J; Dai Z; Zeng Q; Xu B; Lei H
J Ethnopharmacol; 2024 Mar; 322():117652. PubMed ID: 38151178
[TBL] [Abstract][Full Text] [Related]
15. Chinese medicine formula Kai-Xin-San ameliorates depression-like behaviours in chronic unpredictable mild stressed mice by regulating gut microbiota-inflammation-stress system.
Cao C; Liu M; Qu S; Huang R; Qi M; Zhu Z; Zheng J; Chen Z; Wang Z; Han Z; Zhu Y; Huang F; Duan JA
J Ethnopharmacol; 2020 Oct; 261():113055. PubMed ID: 32592887
[TBL] [Abstract][Full Text] [Related]
16. Kai-Xin-San, a standardized traditional Chinese medicine formula, up-regulates the expressions of synaptic proteins on hippocampus of chronic mild stress induced depressive rats and primary cultured rat hippocampal neuron.
Zhu Y; Duan X; Cheng X; Cheng X; Li X; Zhang L; Liu P; Su S; Duan JA; Dong TT; Tsim KW; Huang F
J Ethnopharmacol; 2016 Dec; 193():423-432. PubMed ID: 27660009
[TBL] [Abstract][Full Text] [Related]
17. A Comparative Study of Serum Pharmacochemistry of Kai-Xin-San in Normal and AD Rats Using UPLC-LTQ-Orbitrap-MS.
Yang L; Liang J; Zheng Q; Zhou L; Xiong Y; Wang H; Yuan J
Pharmaceuticals (Basel); 2022 Dec; 16(1):. PubMed ID: 36678527
[TBL] [Abstract][Full Text] [Related]
18. Study on the Multitarget Synergistic Effects of Kai-Xin-San against Alzheimer's Disease Based on Systems Biology.
Guo S; Wang J; Wang Y; Zhang Y; Bi K; Zhang Z; Li Q
Oxid Med Cell Longev; 2019; 2019():1707218. PubMed ID: 31976026
[TBL] [Abstract][Full Text] [Related]
19. Kai-Xin-San Protects Depression Mice Against CORT-Induced Neuronal Injury by Inhibiting Microglia Activation and Oxidative Stress.
Bai G; Jing S; Cao H; Qiao Y; Chen G; Duan L; Yang Y; Li M; Li W; Chang X; Yang C; Wang Q
Evid Based Complement Alternat Med; 2022; 2022():5845800. PubMed ID: 36310618
[TBL] [Abstract][Full Text] [Related]
20. Global identification and determination of the major constituents in Kai-Xin-San by ultra-performance liquid chromatography-quadrupole-Orbitrap mass spectrometry and gas chromatography-mass spectrometry.
Lin R; Yin J; Wu M; Ding H; Han L; Yang W; Song X; Bie S; Wang C; He Y; Yu H; Li Z
J Pharm Biomed Anal; 2021 Nov; 206():114385. PubMed ID: 34597841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
